Zwitter M - Search Results

1

Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily Versus Twice-Daily Radiotherapy (CONVERT) Trial.

Christodoulou M, Blackhall F, Mistry H, Leylek A, Knegjens J, Remouchamps V, Martel-Lafay I, Farré N, Zwitter M, Lerouge D, Pourel N, Janicot H, Scherpereel A, Tissing-Tan C, Peignaux K, Geets X, Konopa K, Faivre-Finn C. Christodoulou M, et al. Among authors: zwitter m. J Thorac Oncol. 2019 Jan;14(1):63-71. doi: 10.1016/j.jtho.2018.09.027. Epub 2018 Oct 31. J Thorac Oncol. 2019. PMID: 30391573 Free PMC article. Clinical Trial.

2

Gemcitabine in brief versus prolonged low-dose infusion, both combined with cisplatin, for advanced non-small cell lung cancer: a randomized phase II clinical trial.

Zwitter M, Kovac V, Smrdel U, Vrankar M, Zadnik V. Zwitter M, et al. J Thorac Oncol. 2009 Sep;4(9):1148-55. doi: 10.1097/JTO.0b013e3181ae280f. J Thorac Oncol. 2009. PMID: 19546818 Free article. Clinical Trial.

3

Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.

Zwitter M, Kovac V, Smrdel U, Strojan P. Zwitter M, et al. J Thorac Oncol. 2006 Sep;1(7):662-6. J Thorac Oncol. 2006. PMID: 17409933 Free article. Clinical Trial.

4

Lung Cancer in Slovenia.

Zwitter M, Čufer T, Vrankar M, Kern I, Štupnik T, Rozman A, Koprivnikar H, Zadnik V. Zwitter M, et al. J Thorac Oncol. 2019 Aug;14(8):1327-1331. doi: 10.1016/j.jtho.2019.02.025. J Thorac Oncol. 2019. PMID: 31345331 Free article. No abstract available.

5

Metastatic adenocarcinoma of the lung in a 27-year-old pregnant woman.

But Hadzic J, Secerov A, Zwitter M, Lamovec J, Kern I, Kavsek G, Hergouth KM, De Greve J. But Hadzic J, et al. Among authors: zwitter m. J Thorac Oncol. 2007 May;2(5):450-2. doi: 10.1097/01.JTO.0000268680.33238.01. J Thorac Oncol. 2007. PMID: 17473662 Free article. No abstract available.

6

Two schedules of chemotherapy for patients with non-small cell lung cancer in poor performance status: a phase II randomized trial.

Zwitter M, Kovac V, Rajer M, Vrankar M, Smrdel U. Zwitter M, et al. Anticancer Drugs. 2010 Jul;21(6):662-8. doi: 10.1097/CAD.0b013e32833ab7a0. Anticancer Drugs. 2010. PMID: 20453635 Clinical Trial.

7

Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trial.

Vrankar M, Zwitter M, Bavcar T, Milic A, Kovac V. Vrankar M, et al. Among authors: zwitter m. Radiol Oncol. 2014 Nov 5;48(4):369-80. doi: 10.2478/raon-2014-0026. eCollection 2014 Dec. Radiol Oncol. 2014. PMID: 25435850 Free PMC article.

8

Intercalated chemotherapy and erlotinib for non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations.

Zwitter M, Rajer M, Stanic K, Vrankar M, Doma A, Cuderman A, Grmek M, Kern I, Kovac V. Zwitter M, et al. Cancer Biol Ther. 2016 Aug 2;17(8):833-9. doi: 10.1080/15384047.2016.1195049. Epub 2016 Jun 3. Cancer Biol Ther. 2016. PMID: 27261103 Free PMC article. Clinical Trial.

9

Immunohistochemistry for EGFR Mutation Detection in Non-Small-Cell Lung Cancer.

Hitij NT, Kern I, Sadikov A, Knez L, Stanič K, Zwitter M, Cufer T. Hitij NT, et al. Among authors: zwitter m. Clin Lung Cancer. 2017 May;18(3):e187-e196. doi: 10.1016/j.cllc.2016.11.021. Epub 2016 Dec 2. Clin Lung Cancer. 2017. PMID: 28089159

10

Dutch statistics on lung cancer: sobering experience for a new approach.

Zwitter M. Zwitter M. J Thorac Oncol. 2012 Feb;7(2):269-71. doi: 10.1097/JTO.0b013e31823ab5fb. J Thorac Oncol. 2012. PMID: 22252561 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page